Skip to Content

2 Results Found

  • Article
  • Open Access
20 Citations
4,453 Views
8 Pages

26 July 2021

Background: The most effective symptomatic treatment in Parkinson’s disease (PD) is levodopa in standard doses. However, as the disease progresses, there may be a need for a more personalized approach and fine tuning, in accordance with the patients’...

(This article belongs to the Special Issue Optimizing Treatment of Parkinson’s Disease)
  • Article
  • Open Access
879 Views
18 Pages

Use of a Slow-Release Phenylalanine-Free Microtablet Protein Substitute in Children and Adolescents with Phenylketonuria: An Observational Pilot Study

  • Martina Tosi,
  • Anne Daly,
  • Catherine Ashmore,
  • Ozlem Yilmaz Nas and ,
  • Alex Pinto,
  • Sharon Evans and
  • Anita MacDonald
  • + 2 authors+ 0 author

21 July 2026

Background/Objectives: In phenylketonuria (PKU), adherence to protein substitute (PS) is frequently suboptimal due to poor palatability, high volume, and sensory fatigue. A novel phenylalanine (Phe)-free L-amino acid microtablet PS has been developed...

(This article belongs to the Section Nutrition and Metabolism)